160 related articles for article (PubMed ID: 36787023)
1. Comparison of the radiomics-based predictive models using machine learning and nomogram for epidermal growth factor receptor mutation status and subtypes in lung adenocarcinoma.
Kawazoe Y; Shiinoki T; Fujimoto K; Yuasa Y; Hirano T; Matsunaga K; Tanaka H
Phys Eng Sci Med; 2023 Mar; 46(1):395-403. PubMed ID: 36787023
[TBL] [Abstract][Full Text] [Related]
2. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.
Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D
Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901
[TBL] [Abstract][Full Text] [Related]
3. A clinically practical radiomics-clinical combined model based on PET/CT data and nomogram predicts EGFR mutation in lung adenocarcinoma.
Chang C; Zhou S; Yu H; Zhao W; Ge Y; Duan S; Wang R; Qian X; Lei B; Wang L; Liu L; Ruan M; Yan H; Sun X; Xie W
Eur Radiol; 2021 Aug; 31(8):6259-6268. PubMed ID: 33544167
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the combination of intratumoral and peritumoral radiomic signatures for predicting epidermal growth factor receptor mutation in lung adenocarcinoma.
Kawazoe Y; Shiinoki T; Fujimoto K; Yuasa Y; Hirano T; Matsunaga K; Tanaka H
J Appl Clin Med Phys; 2023 Jun; 24(6):e13980. PubMed ID: 37002910
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma.
Jiang X; Ren M; Shuang X; Yang H; Shi D; Lai Q; Dong Y
J Magn Reson Imaging; 2021 Aug; 54(2):497-507. PubMed ID: 33638577
[TBL] [Abstract][Full Text] [Related]
6. MRI-based radiomics analysis for predicting the EGFR mutation based on thoracic spinal metastases in lung adenocarcinoma patients.
Ren M; Yang H; Lai Q; Shi D; Liu G; Shuang X; Su J; Xie L; Dong Y; Jiang X
Med Phys; 2021 Sep; 48(9):5142-5151. PubMed ID: 34318502
[TBL] [Abstract][Full Text] [Related]
7. Detailed identification of epidermal growth factor receptor mutations in lung adenocarcinoma: Combining radiomics with machine learning.
Li S; Luo T; Ding C; Huang Q; Guan Z; Zhang H
Med Phys; 2020 Aug; 47(8):3458-3466. PubMed ID: 32416013
[TBL] [Abstract][Full Text] [Related]
8. Combination of
Li S; Li Y; Zhao M; Wang P; Xin J
Korean J Radiol; 2022 Sep; 23(9):921-930. PubMed ID: 36047542
[TBL] [Abstract][Full Text] [Related]
9. MRI-Based Radiomics Nomogram as a Potential Biomarker to Predict the EGFR Mutations in Exon 19 and 21 Based on Thoracic Spinal Metastases in Lung Adenocarcinoma.
Cao R; Dong Y; Wang X; Ren M; Wang X; Zhao N; Yu T; Zhang L; Luo Y; Cui EN; Jiang X
Acad Radiol; 2022 Mar; 29(3):e9-e17. PubMed ID: 34332860
[TBL] [Abstract][Full Text] [Related]
10. Accurate prediction of epidermal growth factor receptor mutation status in early-stage lung adenocarcinoma, using radiomics and clinical features.
Zhu H; Song Y; Huang Z; Zhang L; Chen Y; Tao G; She Y; Sun X; Yu H
Asia Pac J Clin Oncol; 2022 Dec; 18(6):586-594. PubMed ID: 35098682
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases.
Xu J; Yang Y; Gao Z; Song T; Ma Y; Yu X; Shi C
Clin Neurol Neurosurg; 2024 May; 240():108258. PubMed ID: 38552362
[TBL] [Abstract][Full Text] [Related]
12. Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction.
Sun Y; Li C; Jin L; Gao P; Zhao W; Ma W; Tan M; Wu W; Duan S; Shan Y; Li M
Eur Radiol; 2020 Jul; 30(7):3650-3659. PubMed ID: 32162003
[TBL] [Abstract][Full Text] [Related]
13. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
[TBL] [Abstract][Full Text] [Related]
14. Development and externally validate MRI-based nomogram to assess EGFR and T790M mutations in patients with metastatic lung adenocarcinoma.
Fan Y; Dong Y; Wang H; Wang H; Sun X; Wang X; Zhao P; Luo Y; Jiang X
Eur Radiol; 2022 Oct; 32(10):6739-6751. PubMed ID: 35729427
[TBL] [Abstract][Full Text] [Related]
15. Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients-a radiomics nomogram analysis.
Yang X; Liu M; Ren Y; Chen H; Yu P; Wang S; Zhang R; Dai H; Wang C
Eur Radiol; 2022 Apr; 32(4):2693-2703. PubMed ID: 34807270
[TBL] [Abstract][Full Text] [Related]
16. CT-based nomogram for early identification of T790M resistance in metastatic non-small cell lung cancer before first-line epidermal growth factor receptor-tyrosine kinase inhibitors therapy.
Li Y; Lv X; Wang Y; Xu Z; Lv Y; Hou D
Eur Radiol Exp; 2023 Nov; 7(1):64. PubMed ID: 37914925
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases.
Qi H; Hou Y; Zheng Z; Zheng M; Qiao Q; Wang Z; Sun X; Xing L
BMC Cancer; 2024 Mar; 24(1):362. PubMed ID: 38515096
[TBL] [Abstract][Full Text] [Related]
18. Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma.
Nie P; Yang G; Wang N; Yan L; Miao W; Duan Y; Wang Y; Gong A; Zhao Y; Wu J; Zhang C; Wang M; Cui J; Yu M; Li D; Sun Y; Wang Y; Wang Z
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):217-230. PubMed ID: 32451603
[TBL] [Abstract][Full Text] [Related]
19. Radiomics for the prediction of EGFR mutation subtypes in non-small cell lung cancer.
Li S; Ding C; Zhang H; Song J; Wu L
Med Phys; 2019 Oct; 46(10):4545-4552. PubMed ID: 31376283
[TBL] [Abstract][Full Text] [Related]
20. Machine Learning-Based Radiomics for Prediction of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma.
Lu J; Ji X; Wang L; Jiang Y; Liu X; Ma Z; Ning Y; Dong J; Peng H; Sun F; Guo Z; Ji Y; Xing J; Lu Y; Lu D
Dis Markers; 2022; 2022():2056837. PubMed ID: 35578691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
